MADRONE CAPITAL PARTNERS LLC 13D and 13G filings for Pacific Biosciences of California, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:48 pm Purchase | 2024-09-30 | 13G | Pacific Biosciences of California, Inc. PACB | MADRONE CAPITAL PARTNERS LLC | 26,891,915 9.900% | 5,800,000 (+27.50%) | Filing |
| 2024-02-13 4:15 pm Purchase | 2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | MADRONE CAPITAL PARTNERS LLC | 21,091,915 7.900% | 1,175,982 (+5.90%) | Filing |
| 2023-02-13 4:03 pm Purchase | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | MADRONE CAPITAL PARTNERS LLC | 19,915,933 8.800% | 3,000,000 (+17.73%) | Filing |
| 2022-06-01 4:00 pm Purchase | 2022-03-15 | 13G | Pacific Biosciences of California, Inc. PACB | MADRONE CAPITAL PARTNERS LLC | 16,915,933 7.500% | 16,915,933 (New Position) | Filing |